Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Scully

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|April 5, 2012
Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidisAnnaliesa S Anderson, Ingrid L Scully, Yekaterina Timofeyeva, et al.
Vaccine|August 31, 2015
Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infectionIngrid L Scully, Yekaterina Timofeyeva, David Keeney, et al.
Open Forum Infectious Diseases|June 22, 2026
Maternal and Newborn Group B <i>Streptococcus</i> Serology in the United States and South AfricaBarbara A Pahud, Shabir A Madhi, Nicola P Klein, et al.
Clinical and Vaccine Immunology : CVI|August 17, 2012
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposureJulio Hawkins, Srinivas Kodali, Yury V Matsuka, et al.
The Pediatric Infectious Disease Journal|March 27, 2024
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsShelly Senders, Nicola P Klein, Noor Tamimi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2023
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine ImmunogenicityKelly Sackett, Paul Brown, Kaushik Dutta, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureusJasdeep S Nanra, Sandra M Buitrago, Shomari Crawford, et al.
Toxicologic Pathology|April 24, 2009
Spontaneous hibernomas in Sprague-Dawley ratsRichard H Bruner, Meliton N Novilla, Catherine A Picut, et al.
Vaccine|July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15ALi Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2021
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 YearsBrandon Essink, Charu Sabharwal, Kevin Cannon, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|April 5, 2012
Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidisAnnaliesa S Anderson, Ingrid L Scully, Yekaterina Timofeyeva, et al.
Vaccine|August 31, 2015
Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infectionIngrid L Scully, Yekaterina Timofeyeva, David Keeney, et al.
Open Forum Infectious Diseases|June 22, 2026
Maternal and Newborn Group B <i>Streptococcus</i> Serology in the United States and South AfricaBarbara A Pahud, Shabir A Madhi, Nicola P Klein, et al.
Clinical and Vaccine Immunology : CVI|August 17, 2012
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposureJulio Hawkins, Srinivas Kodali, Yury V Matsuka, et al.
The Pediatric Infectious Disease Journal|March 27, 2024
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsShelly Senders, Nicola P Klein, Noor Tamimi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2023
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine ImmunogenicityKelly Sackett, Paul Brown, Kaushik Dutta, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureusJasdeep S Nanra, Sandra M Buitrago, Shomari Crawford, et al.
Toxicologic Pathology|April 24, 2009
Spontaneous hibernomas in Sprague-Dawley ratsRichard H Bruner, Meliton N Novilla, Catherine A Picut, et al.
Vaccine|July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15ALi Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2021
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 YearsBrandon Essink, Charu Sabharwal, Kevin Cannon, et al.
Pageof 10